Evotec - Research never stops
  • Loading...

Archive



Dec 21, 2004

Evotec Technologies provides EVOscreen® and Opera to Korea

- read more
Nov 11, 2004

Third Quarter 2004: On Track to Reach Updated Financial Targets

- read more
Oct 20, 2004

Evotec OAI Updates Guidance for 2004 and Provides Preliminary Third Quarter Revenues

- read more
Oct 06, 2004

ALTANA Pharma Selects Evotec OAI as Partner for a Kinase Lead Identification Programme

- read more
Sep 13, 2004

Evotec Technologies and QIAGEN Demonstrate Significant Benefits of Combining High-Content Cellular Imaging Systems with RNAi Applications

- read more
Sep 08, 2004

Evotec Neurosciences and Evotec OAI Enter into Joint Drug Discovery Collaboration with Boehringer Ingelheim to Identify GPCR Modulator-based New Medicines

- read more
Aug 26, 2004

Bernard Questier Leaves Management Board of Evotec OAI

- read more
Aug 11, 2004

Seikagaku Selects Evotec OAI as Assay Development and Screening Partner

- read more
Aug 11, 2004

Second Quarter 2004: Revenues Rebound From Q1 - Good Progress in Difficult Market Environment

- read more
Jul 29, 2004

Evotec OAI to Apply New Rational Drug Design Platform, EVOrationale(TM), to High Priority Research Programme from ActivBiotics

- read more
Jul 21, 2004

Morphochem Selects Evotec OAI as a Partner for the Chemical and Pharmaceutical Development of its Dual Action Antibiotic Oxaquin

- read more
Jul 19, 2004

Biogen Idec Selects Evotec OAI as a Service Provider for Process Research & Development

- read more
Jul 12, 2004

Evotec OAI Announces Preliminary Q2 Sales Significantly Improved from Q1 2004 - On Track to Meet Full-Year Guidance

- read more
Jun 18, 2004

Evotec OAI Undergoes Successful FDA Inspection

- read more
Jun 14, 2004

Neuronova AG Selects Evotec OAI as their Assay Development and Screening Partner

- read more
May 19, 2004

Evotec OAI Enters into Discovery Agreement with Nuvios

- read more
May 13, 2004

Guilford Pharmaceuticals Selects Evotec OAI as their Assay Development and Screening Partner

- read more
May 12, 2004

Evotec OAI and Roche enter into Strategic Global Discovery Chemistry Agreement

- read more
May 12, 2004

First Quarter 2004: Delivering on Forecast and Strategy

- read more
May 07, 2004

Evotec OAI Expands ADMET Platform, EVOprofile

- read more
Apr 26, 2004

Evotec OAI to Expand Agreement with Oxford Bioscience Partners through Integration of its New Rational Drug Design Platform, EVOrational

- read more
Apr 13, 2004

Evotec OAI Enters into Integrated Virtual Screening and Medicinal Chemistry Agreement with Fujisawa

- read more
Apr 02, 2004

Evotec Neurosciences Completes € 25 Million Series A Financing

- read more
Mar 25, 2004

Evotec OAI and Panacos Enter into Medicinal Chemistry Agreement to Design and Optimise Novel Anti-HIV Compounds

- read more
Mar 25, 2004

Evotec Neurosciences to licence NMDA receptor NR2B subunit selective antagonists from Roche

- read more
Mar 25, 2004

Evotec OAI AG - Financial Results 2003: Strategy delivers strong revenue growth and positive EBITDA

- read more
Feb 17, 2004

Evotec OAI Announces Re-organisation of it's Executive Management to Reflect the Growing Strengths of its Core Businesses

- read more
Feb 16, 2004

Evotec OAI's Preliminary Results 2003 Show Strong Sales Growth and Robust EBITDA Profitability

- read more
Feb 11, 2004

Evotec OAI and Toray Sign Integrated Medicinal Chemistry, Virtual Screening and Compound Profiling Agreement

- read more
Jan 14, 2004

Evotec OAI and Rib-X Pharmaceuticals Enter Into Medicinal Chemistry Collaboration

- read more